دورية أكاديمية
أعرض في EDS

Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data.

التفاصيل البيبلوغرافية
العنوان: Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data.
المؤلفون: Aoki Y; Clinical Pharmacology and Safety Sciences, AstraZeneca, Gothenburg, Sweden., Cabrera CS; Real World Science and Digital, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Ouwens M; Biometrics Oncology, AstraZeneca, Gothenburg, Sweden., Bamberg K; Early Clinical Development, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Nyström J; The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Raz I; Hadassah University Hospital, Jerusalem, Israel., Scirica BM; Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America., Hamrén B; Clinical Pharmacology and Safety Sciences, AstraZeneca, Gothenburg, Sweden., Greasley PJ; Early Clinical Development, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rekić D; Clinical Pharmacology and Safety Sciences, AstraZeneca, Gothenburg, Sweden.
المصدر: PloS one [PLoS One] 2022 Jun 21; Vol. 17 (6), pp. e0269970. Date of Electronic Publication: 2022 Jun 21 (Print Publication: 2022).
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Diabetes Mellitus* , Diabetes Mellitus, Type 2* , Renal Insufficiency, Chronic*, Albuminuria/complications ; Bilirubin ; Disease Progression ; Glomerular Filtration Rate ; Humans ; Kidney ; Risk Factors
مستخلص: Objective: To evaluate if previously found associations between low serum bilirubin concentration and kidney function decline is independent of hemoglobin and other key confounders.
Research Design and Methods: Clinical trial data from the SAVOR-TIMI 53 trial as well as the UK primary care electronic healthcare records, Clinical Practice Research Datalink (CPRD), were used to construct three cohorts of patients at risk of chronic kidney disease (CKD). The randomized clinical trial (RCT) cohort from the subset of SAVOR-TIMI 53 trial consisted of 10,555 type-2 diabetic patients with increased risk of cardiovascular disease. The two observational data cohorts from CPRD consisted of 71,104 newly diagnosed type-2 diabetes (CPRD-DM2) and 82,065 newly diagnosed hypertensive (CPRD-HT) patients without diabetes. Cohorts were stratified according to baseline circulating total bilirubin levels to determine association on the primary end point of a 30% reduction from baseline in estimated glomerular filtration rate (eGFR) and the secondary end point of albuminuria.
Results: The confounder adjusted hazard ratios of the subpopulation with lower than median bilirubin levels compared to above median bilirubin levels for the primary end point were 1.18 (1.02-1.37), 1.12 (1.05-1.19) and 1.09 (1.01-1.17), for the secondary end point were 1.26 (1.06-1.52), 1.11 (1.01-1.21) and 1.18 (1.01-1.39) for SAVOR-TIMI 53, CPRD-DM2, CPRD-HT, respectively.
Conclusion: Our findings are consistent across all cohorts and endpoints: lower serum bilirubin levels are associated with a greater kidney function decline independent of hemoglobin and other key confounders. This suggests that increased monitoring of kidney health in patients with lower bilirubin levels may be considered, especially for diabetic patients.
Competing Interests: The authors have declared that no competing interests exist.
References: J Diabetes Complications. 2016 Sep-Oct;30(7):1255-60. (PMID: 27288202)
Kidney Int. 2008 Nov;74(9):1197-201. (PMID: 18854849)
J Diabetes Complications. 2015 Nov-Dec;29(8):1223-7. (PMID: 26234498)
JAMA. 2011 Feb 16;305(7):691-7. (PMID: 21325185)
J Am Heart Assoc. 2017 Dec 23;6(12):. (PMID: 29275374)
Metabolism. 2015 Sep;64(9):1096-102. (PMID: 26142826)
Ann Intern Med. 2009 May 5;150(9):604-12. (PMID: 19414839)
Clin Pharmacol Ther. 2019 Sep;106(3):568-575. (PMID: 30588615)
BMJ Open. 2017 May 29;7(5):e014694. (PMID: 28554919)
Diabetes Metab. 2015 Nov;41(5):429-31. (PMID: 26054296)
J Diabetes Complications. 2018 Nov;32(11):1000-1005. (PMID: 30224234)
Clin Chim Acta. 2018 May;480:9-16. (PMID: 29408172)
CMAJ. 2012 Aug 7;184(11):1265-9. (PMID: 22371511)
Am J Physiol Renal Physiol. 2014 Jul 15;307(2):F123-36. (PMID: 24761005)
J Clin Pathol. 1989 Feb;42(2):172-9. (PMID: 2921359)
Int Urol Nephrol. 2018 Feb;50(2):275-287. (PMID: 28808864)
Clin Exp Nephrol. 2014 Dec;18(6):876-84. (PMID: 24448692)
Curr Hypertens Rep. 2017 Jul;19(7):58. (PMID: 28597405)
Clin Biochem. 2017 Dec;50(18):1040-1047. (PMID: 28834701)
Front Med (Lausanne). 2021 Jan 25;7:549. (PMID: 33569386)
Br J Biomed Sci. 2016 Oct;73(4):188-193. (PMID: 27231984)
BMC Nephrol. 2017 Mar 31;18(1):114. (PMID: 28363276)
Zhonghua Yi Xue Za Zhi. 2018 Aug 14;98(30):2403-2406. (PMID: 30138984)
Int J Mol Sci. 2018 Dec 29;20(1):. (PMID: 30597982)
Epidemiology. 1999 Jan;10(1):37-48. (PMID: 9888278)
Diabetes. 2014 Aug;63(8):2613-6. (PMID: 25060893)
Korean J Intern Med. 2017 Sep;32(5):875-882. (PMID: 28560862)
N Engl J Med. 2013 Oct 3;369(14):1317-26. (PMID: 23992601)
Diabetes. 2014 Aug;63(8):2845-53. (PMID: 24677717)
Circulation. 2006 Oct 3;114(14):1476-81. (PMID: 17000907)
Int J Epidemiol. 2015 Jun;44(3):827-36. (PMID: 26050254)
Br J Clin Pharmacol. 1995 Feb;39(2):169-71. (PMID: 7742155)
PLoS One. 2017 Feb 22;12(2):e0172434. (PMID: 28225832)
Angiology. 2017 Sep;68(8):728-733. (PMID: 27852844)
Diabetes. 2015 Apr;64(4):1459-69. (PMID: 25368098)
Stat Med. 2015 Dec 10;34(28):3661-79. (PMID: 26238958)
Diabetes Care. 2014;37(1):252-8. (PMID: 24009299)
Sci Rep. 2017 Jan 30;7:41681. (PMID: 28134328)
Pediatr Diabetes. 2017 Dec;18(8):803-807. (PMID: 28093842)
Int J Epidemiol. 2019 Dec 1;48(6):1740-1740g. (PMID: 30859197)
المشرفين على المادة: RFM9X3LJ49 (Bilirubin)
تواريخ الأحداث: Date Created: 20220621 Date Completed: 20220623 Latest Revision: 20220718
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC9212140
DOI: 10.1371/journal.pone.0269970
PMID: 35727760
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0269970